Arcutis Biotherapeutics, Inc.
NASDAQ:ARQT · NASDAQ Global Select
-$0.51 today
Vol 5.46M · Avg 1.61M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+82.01%
Period High
$31.20
Period Low
$13.39
Latest
$26.21
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.17B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.39B
Legend Biotech Corporation
NASDAQ:LEGN
$5.36B
Travere Therapeutics, Inc.
NASDAQ:TVTX
$5.06B
Amicus Therapeutics, Inc.
FOLD
$4.55B
Celcuity Inc.
NASDAQ:CELC
$4.20B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.17B
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$2.70B
Disc Medicine, Inc.
NASDAQ:IRON
$2.69B
Zai Lab Limited
NASDAQ:ZLAB
$2.09B
What is the latest ARQT filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does ARQT have?
Intrinsic Alpha currently shows 20 recent filings for ARQT.
Explore More
Continue the stock analysis
Jump to another research area for this company.